Synthesis method of novel Gd2O3@Fe3O4 nanocomposite modified by dextrose capping agent

Abstract In current study, gadolinium oxide was heterogeneously formed on the surface of iron oxide nanoparticles and further modified with dextrose capping agent to be used in biomedical applications, especially for contrast enhancement in MR images. First, two types of iron oxide nanoparticles were prepared at 25 and 80 °C via simple coprecipitaion method. Then, gadolinium oxide nanoparticles were synthesized through a consecutive precipitation process on previously formed iron oxide seeds in an aqueous media and subsequent annealing at 300 °C. Finally, dextrose was used as capping agent to stabilize nanocomposites in a colloidal suspension. X-ray diffraction (XRD), Scanning and Transmission electron microscopy, Dynamic Laser Scattering (DLS), Fourier-Transform Infrared Spectroscopy (FTIR), and Magnetometery (VSM) techniques were employed for nanocomposites investigation and MTT-assay method used for viability assessment of colloidal samples. Measurements based on Scherrer equation from XRD patterns showed that increasing coprecipitation temperature resulted bigger iron oxide crystallites. The iron oxide crystallite size was increased from 15.1 to 28.1 nm. Precipitation process led to gadolinium oxide formation with 30.7 and 38.8 nm crystallite sizes, respectively. TEM images revealed that iron oxide agglomerates were encapsulated in gadolinium oxide surroundings. Hydrodynamic size of the coated nanoparticles with dextrose was 208 and 247 nm. In VSM examinations, nanocomposites did not display coercive field and the saturation magnetization was 1.93 emu/g. MTT-assay results showed 80% viability in 285 μg nanocomposites containing 96.9 μg [Fe] and 11.4 μg [Gd].